1
|
Porszasz J, Wang CY, Ferguson C, Ma S, Girardi M, Stringer WW. Letter to the editor in response to Hoskote "Corrected formula for rectangular area ratio (RAR), a parameter used to quantify airflow limitation on expiratory flow-volume curves" Respiratory Medicine 2022; 204: 107032. Respir Med 2023:107304. [PMID: 37257784 DOI: 10.1016/j.rmed.2023.107304] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/12/2023] [Accepted: 05/27/2023] [Indexed: 06/02/2023]
Affiliation(s)
- Janos Porszasz
- The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, 1124 W. Carson St. Torrance, CA, 90502, USA.
| | - Chu-Yi Wang
- The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, 1124 W. Carson St. Torrance, CA, 90502, USA
| | - Carrie Ferguson
- The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, 1124 W. Carson St. Torrance, CA, 90502, USA
| | - Shuyi Ma
- The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, 1124 W. Carson St. Torrance, CA, 90502, USA
| | - Michele Girardi
- The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, 1124 W. Carson St. Torrance, CA, 90502, USA
| | - William W Stringer
- The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, 1124 W. Carson St. Torrance, CA, 90502, USA
| |
Collapse
|
2
|
Hoskote SS. Corrected formula for rectangular area ratio (RAR), a parameter used to quantify airflow limitation on expiratory flow-volume curves. Respir Med 2022; 204:107032. [DOI: 10.1016/j.rmed.2022.107032] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/23/2022] [Accepted: 10/26/2022] [Indexed: 11/06/2022]
|
3
|
Chuang ML. Tidal volume expandability affected by flow, dynamic hyperinflation, and quasi-fixed inspiratory time in patients with COPD and healthy individuals. Chron Respir Dis 2022; 19:14799731221133390. [PMID: 36210794 PMCID: PMC9549191 DOI: 10.1177/14799731221133390] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Exertional dyspnea (ED) and impaired exercise performance (EP) are mainly caused
by dynamic hyperinflation (DH) in chronic obstructive pulmonary disease (COPD)
patients by constraining tidal volume expansion at peak exercise
(VTpeak). As VTpeak is the product of inspiratory time
(TIpeak) and flow (VT/TIpeak), it was
hypothesized that VTpeak and VTpeak/total lung capacity
(VTpeak/TLC) may be affected by TIpeak and
VT/TIpeak. Hence, the study investigated the (1)
effect of TIpeak and VT/TIpeak on
VTpeak expansion, (2) factors associated with TIpeak,
expiratory time (TEpeak), VT/TIpeak, and
VTpeak/TLC, and (3) relationships between
VT/TIpeak and VTpeak/TLC with ED and EP in
COPD patients and controls. The study enrolled 126 male stable COPD patients and
33 sex-matched controls. At peak exercise, TIpeak was similar in all
subjects (COPD versus controls, mean ± SD: 0.78 ± 0.17 s versus 0.81 ± 0.20 s,
p = NS), whereas the COPD group had lower
VT/TIpeak (1.71 ± 0.49 L/s versus 2.58 ± 0.69 L/s,
p < .0001) and thus the COPD group had smaller
VTpeak (1.31 ± 0.34 L versus 2.01 ± 0.45 L,p
< .0001) and VTpeak/TLC (0.22 ± 0.06 vs 0.33 ± 0.05,
p < .0001). TIpeak, TEpeak, and
VT/TIpeak were mainly affected by exercise effort,
whereas VTpeak/TLC was not. TEpeak,
VT/TIpeak, and VTpeak/TLC were inversely
changed by impaired lung function. TIpeak was not affected by lung
function. Dynamic hyperinflation did not occur in the controls, however,
VTpeak/TLC was strongly inversely related to DH (r = −0.79) and
moderately to strongly related to lung function, ED, and EP in the COPD group.
There was a slightly stronger correlation between VTpeak/TLC with ED
and EP than VT/TIpeak in the COPD group (|r| = 0.55–0.56
vs 0.38–0.43). In summary, TIpeak was similar in both groups and the
key to understanding how flow affects lung expansion. However, the DH volume
effect was more important than the flow effect on ED and EP in the COPD
group.
Collapse
Affiliation(s)
- Ming-Lung Chuang
- Division of Pulmonary Medicine and
Department of Internal Medicine, Chung Shan Medical University
Hospital, Taichung, Taiwan
- School of Medicine, Chung Shan Medical
University, Taichung, Taiwan
- Ming-Lung Chuang, Department of Critical
Care Medicine and Division of Pulmonary Medicine, Chung Shan Medical University
Hospital, ROC;#110, Section 1, Chien-Kuo North Road, South District, 110,
Section 1, Chien-Kuo North Road, South District, Taichung 40201, Taiwan.
| |
Collapse
|
4
|
Tiller NB, Cao M, Lin F, Yuan W, Wang CY, Abbasi A, Calmelat R, Soriano A, Rossiter HB, Casaburi R, Stringer WW, Porszasz J. Dynamic airway function during exercise in COPD assessed via impulse oscillometry before and after inhaled bronchodilators. J Appl Physiol (1985) 2021; 131:326-338. [PMID: 34013748 PMCID: PMC8325613 DOI: 10.1152/japplphysiol.00148.2021] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2021] [Revised: 05/14/2021] [Accepted: 05/16/2021] [Indexed: 01/21/2023] Open
Abstract
Assessing airway function during exercise provides useful information regarding mechanical properties of the airways and the extent of ventilatory limitation in COPD. The primary aim of this study was to use impulse oscillometry (IOS) to assess dynamic changes in airway impedance across a range of exercise intensities in patients with GOLD 1-4, before and after albuterol administration. A secondary aim was to assess the reproducibility of IOS measures during exercise. Fifteen patients with COPD (8 males/7 females; age = 66 ± 8 yr; prebronchodilator FEV1 = 54.3 ± 23.6%Pred) performed incremental cycle ergometry before and 90 min after inhaled albuterol. Pulmonary ventilation and gas exchange were measured continuously, and IOS-derived indices of airway impedance were measured every 2 min immediately preceding inspiratory capacity maneuvers. Test-retest reproducibility of exercise IOS was assessed as mean difference between replicate tests in five healthy subjects (3 males/2 females). At rest and during incremental exercise, albuterol significantly increased airway reactance (X5) and decreased airway resistance (R5, R5-R20), impedance (Z5), and end-expiratory lung volume (60% ± 12% vs. 58% ± 12% TLC, main effect P = 0.003). At peak exercise, there were moderate-to-strong associations between IOS variables and IC, and between IOS variables and concavity in the expiratory limb of the spontaneous flow-volume curve. Exercise IOS exhibited moderate reproducibility in healthy subjects which was strongest with R5 (mean diff. = -0.01 ± 0.05 kPa/L/s; ICC = 0.68), R5-R20 (mean diff. = -0.004 ± 0.028 kPa/L/s; ICC = 0.65), and Z5 (mean diff. = -0.006 ± 0.021 kPa/L/s; ICC = 0.69). In patients with COPD, exercise evoked increases in airway resistance and decreases in reactance that were ameliorated by inhaled bronchodilators. The technique of exercise IOS may aid in the clinical assessment of dynamic airway function during exercise.NEW & NOTEWORTHY This study provides a novel, mechanistic insight into dynamic airway function during exercise in COPD, before and after inhaled bronchodilators. The use of impulse oscillometry (IOS) to evaluate airway function is unique among exercise studies. We show strong correlations among IOS variables, dynamic hyperinflation, and shape-changes in the spontaneous expiratory flow-volume curve. This approach may aid in the clinical assessment of airway function during exercise.
Collapse
Affiliation(s)
- Nicholas B Tiller
- Division of Respiratory and Critical Care Physiology and Medicine, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California
| | - Min Cao
- Division of Respiratory and Critical Care Physiology and Medicine, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California
- Department of Respiratory and Critical Care Medicine, Beijing Chest Hospital, Capital Medical University, Beijing, People's Republic of China
| | - Fang Lin
- Division of Respiratory and Critical Care Physiology and Medicine, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California
- Department of Respiratory, Beijing Friendship Hospital, Capital Medical University, Beijing, People's Republic of China
| | - Wei Yuan
- Division of Respiratory and Critical Care Physiology and Medicine, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California
- Department of Respiratory, Beijing Friendship Hospital, Capital Medical University, Beijing, People's Republic of China
| | - Chu-Yi Wang
- Department of Industrial and Systems Engineering, University of Southern California, Los Angeles, California
| | - Asghar Abbasi
- Division of Respiratory and Critical Care Physiology and Medicine, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California
| | - Robert Calmelat
- Division of Respiratory and Critical Care Physiology and Medicine, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California
| | - April Soriano
- Division of Respiratory and Critical Care Physiology and Medicine, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California
| | - Harry B Rossiter
- Division of Respiratory and Critical Care Physiology and Medicine, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California
| | - Richard Casaburi
- Division of Respiratory and Critical Care Physiology and Medicine, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California
| | - William W Stringer
- Division of Respiratory and Critical Care Physiology and Medicine, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California
| | - Janos Porszasz
- Division of Respiratory and Critical Care Physiology and Medicine, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California
| |
Collapse
|
5
|
Erram J, Bari M, Domingo A, Cannon DT. Pulmonary function with expiratory resistive loading in healthy volunteers. PLoS One 2021; 16:e0252916. [PMID: 34115812 PMCID: PMC8195373 DOI: 10.1371/journal.pone.0252916] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2020] [Accepted: 05/25/2021] [Indexed: 11/19/2022] Open
Abstract
Expiratory flow limitation is a key characteristic in obstructive pulmonary diseases. To study abnormal lung mechanics isolated from heterogeneities of obstructive disease, we measured pulmonary function in healthy adults with expiratory loading. Thirty-seven volunteers (25±5 yr) completed spirometry and body plethysmography under control and threshold expiratory loading of 7, 11 cmH2O, and a subset at 20 cmH2O (n = 11). We analyzed the shape of the flow-volume relationship with rectangular area ratio (RAR; Ma et al., Respir Med 2010). Airway resistance was increased (p<0.0001) with 7 and 11 cmH2O loading vs control (9.20±1.02 and 11.76±1.68 vs. 2.53± 0.80 cmH2O/L/s). RAR was reduced (p = 0.0319) in loading vs control (0.45±0.07 and 0.47±0.09L vs. 0.48±0.08). FEV1 was reduced (p<0.0001) in loading vs control (3.24±0.81 and 3.23±0.80 vs. 4.04±1.05 L). FVC was reduced (p<0.0001) in loading vs control (4.11±1.01 and 4.14±1.03 vs. 5.03±1.34 L). Peak expiratory flow (PEF) was reduced (p<0.0001) in loading vs control (6.03±1.67 and 6.02±1.84 vs. 8.50±2.81 L/s). FEV1/FVC (p<0.0068) was not clinically significant and FRC (p = 0.4) was not different in loading vs control. Supra-physiologic loading at 20 cmH2O did not result in further limitation. Expiratory loading reduced FEV1, FVC, PEF, but there were no clinically meaningful differences in FEV1/FVC, FRC, or RAR. Imposed expiratory loading likely leads to high airway pressures that resist dynamic airway compression. Thus, a concave expiratory flow-volume relationship was consistently absent-a key limitation for model comparison with pulmonary function in COPD. Threshold loading may be a useful strategy to increase work of breathing or induce dynamic hyperinflation.
Collapse
Affiliation(s)
- Jyotika Erram
- School of Exercise & Nutritional Sciences, San Diego State University, San Diego, California, United States of America
| | - Monica Bari
- School of Exercise & Nutritional Sciences, San Diego State University, San Diego, California, United States of America
| | - Antoinette Domingo
- School of Exercise & Nutritional Sciences, San Diego State University, San Diego, California, United States of America
| | - Daniel T. Cannon
- School of Exercise & Nutritional Sciences, San Diego State University, San Diego, California, United States of America
- * E-mail:
| |
Collapse
|
6
|
Stringer W, Marciniuk D. The Role of Cardiopulmonary Exercise Testing (CPET) in Pulmonary Rehabilitation (PR) of Chronic Obstructive Pulmonary Disease (COPD) Patients. COPD 2018; 15:621-631. [PMID: 30595047 DOI: 10.1080/15412555.2018.1550476] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
Abstract
Chronic obstructive pulmonary disease (COPD) is a common multisystem inflammatory disease with ramifications involving essentially all organ systems. Pulmonary rehabilitation is a comprehensive program designed to prevent and mitigate these disparate systemic effects and improve patient quality of life, functional status, and social functioning. Although initial patient assessment is a prominent component of any pulmonary rehabilitation (PR) program, cardiopulmonary exercise testing (CPET) is not regularly performed as a screening physiologic test prior to PR in COPD patients. Further, CPET is not often used to assess or document the improvement in exercise capacity related to completion of PR. In this review we will describe the classic physiologic abnormalities related to COPD on CPET parameters, the role of CPET in Risk Stratification/Safety prior to PR, the physiologic changes that occur in CPET parameters with PR, and the literature regarding the use of CPET to assess PR results. Finally, we will compare CPET to 6MW in COPD PR, the common minimal clinically important difference (MCID) is associated with CPET, and the potential future roles of CPET in PR and Research.
Collapse
Affiliation(s)
- William Stringer
- a Chronic Diseases Clinical Research Center (CDCRC), Los Angeles Biomedical Institute at Harbor-UCLA Medical Center , David Geffen School of Medicine at UCLA , Torrance , CA , USA
| | - Darcy Marciniuk
- b Respiratory Research Center, Royal University Hospital , University of Saskatchewan , Saskatoon , Canada
| |
Collapse
|